Article Author:
Reuters
The Biden administration decided to expand the limited supply of monkeypox vaccine and decided to allow an alternative injection method that uses one-fifth the dose per dose, according to the report. The New York Times reported Monday, citing a senior official familiar with the plans.
The United States declared monkeypox a public health emergency last week in a bid to step up the US response to contain the epidemic.
For the U.S. Food and Drug Administration (FDA) to approve intradermal injection, one-fifth of the current dose would have to be injected into the skin instead of injecting the full amount into the underlying fat. I have. (HHS) must issue a new emergency declaration to allow regulators to exercise the FDA's emergency use authority, the report said.
An announcement is expected as early as Tuesday afternoon, according to the paper. (https://nyti.ms/3P7QSFZ)
The White House, HHS, and FDA did not immediately respond to Reuters requests for comment.
Earlier this month, Biden announced his administration's response to monkeypox. In recent years, monkeypox has not been endemic in more than 80 cases, following the declaration of a state of emergency by the states of California, Illinois, and New York. The country is reporting an outbreak of viral illness, and the World Health Organization has declared a global health emergency. Deaths have been reported.
First identified in monkeys in 1958, the disease causes mild symptoms such as fever, pain, and pus-filled skin lesions, and people are stricken with it. It tends to recover within 2 to 4 weeks, according to WHO.It is spread by close physical contact and is rarely fatal. Edit)
